Craig Barrows is CLO & VP at ImmunoGen, Inc. (IMGN). They have made 6 open-market trades across 2 companies since 2007, most recently 2020-02-24.
CIK 0001177813
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $17K since 2016, against 5 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| IMGN | SELL | 2020-02-24 | 2020-02-25 | $4.99 | $165K | -12.9% | -26.4% | +1.4% |
| IMGN | SELL | 2018-02-22 | 2019-02-25 | $5.60 | $83K | -55.8% | -57.1% | -67.1% |
| IMGN | SELL | 2018-02-21 | 2018-02-23 | $10.88 | $337K | +3.9% | +15.5% | -5.6% |
| IMGN | SELL | 2017-09-13 | 2017-09-15 | $6.80 | $656K | +7.5% | -11.8% | -1.5% |
| IMGN | BUY | 2016-11-02 | 2016-11-03 | $1.71 | $17K | +33.5% | +24.2% | +45.3% |
| MRCY | SELL | 2007-03-12 | 2007-03-13 | $12.51 | $16K | -8.0% | +0.3% | +0.3% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.